Investing Ideas
/
Chilean Pharmaceuticals & Biotech Potentially Undervalued Companies

Chilean Pharmaceuticals & Biotech Potentially Undervalued Companies

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Companies with a Value score of at least 3, ordered by Value score

8 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
MRKCL Merck	CL$99,470.00	0%	8.3%	CL$251.6b	CL$128,752.69	PE20.7x	E16.0%	3.3%
MRK Merck	US$128.80	0%	24.2%	US$251.6b	US$166.72	PE20.7x	E16.0%	3.3%
GILDCL Gilead Sciences	CL$79,000.00	0%	n/a	CL$117.1b	CL$83,179.14	PE929.3x	E40.7%	3.3%
BIIBCL Biogen	CL$155,330.00	0%	-40.5%	CL$21.7b	CL$253,111.11	PE13.4x	E13.6%	n/a
BIIB Biogen	US$245.00	0%	0%	US$21.7b	US$399.23	PE13.4x	E13.6%	n/a
GILD Gilead Sciences	US$89.71	0%	36.9%	US$117.1b	US$94.46	PE929.3x	E40.7%	3.3%
AMGNCL Amgen	CL$305,690.00	0%	n/a	CL$142.2b	CL$372,654.51	PE33.6x	E18.5%	3.6%
AMGN Amgen	US$255.16	0%	0%	US$142.2b	US$311.06	PE33.6x	E18.5%	3.6%

Page 1 of 1